You are here

Gallup Poll: Americans Continue to See Health Care as Top Financial Problem

Low-income families have greatest concern

According to a new Gallup survey, health care costs and the lack of money or low wages are the most important financial problems facing American families, each mentioned by 14% of U.S. adults.

Gallup has been asking Americans about the most important financial problem facing their families in an open-ended format for the past 10 years. This year, health care has returned to the top of the list for the first time since early 2010, when the Patient Protection and Affordable Care Act was signed into law. Still, Americans viewed it as an even bigger financial problem in 2007, when a range of 16% to 19% said it was most important.

The nation’s concern about health care costs varied across income groups. The topic was cited as a concern by 10% of Americans with an annual household income under $30,000; by 18% of those with an annual income of $30,000 to $74,999; and by 13% of those with an annual income of $75,000 or more. Perhaps not surprisingly, lower-income Americans named “lack of money/cash flow” and “not enough money to pay debts” as their top money woes.

“Americans have consistently cited health care, a topic of fierce debate this decade, as one of the most important financial problems, and it remains so,” Gallup concludes.

The results of the survey were based on telephone interviews conducted January 5–8, 2015, with a random sample of 804 adults, aged 18 years and older, living in all 50 U.S. states and the District of Columbia.

Source: Gallup; January 21, 2015.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs